Michael Gelband’s Doximity DOCS Stock Holding History

Michael Gelband’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-93,595	Closed	-$4.14M	–	1676
2025 Q4	$4.14M	Buy	+93,595	New	+$5.25M	0.03%	545
2025 Q1	–	Sell	-39,685	Closed	-$2.12M	–	1580
2024 Q4	$2.12M	Buy	+39,685	New	+$1.94M	0.01%	692
2024 Q3	–	Sell	-125,173	Closed	-$3.5M	–	1723
2024 Q2	$3.5M	Buy	+125,173	New	+$3.3M	0.02%	564
2023 Q4	–	Sell	-74,072	Closed	-$1.57M	–	1590
2023 Q3	$1.57M	Buy	74,072 +7,779	+12%	+$212K	0.02%	769
2023 Q2	$2.25M	Buy	66,293 +43,808	+195%	+$1.46M	0.02%	763
2023 Q1	$728K	Sell	22,485 -5,141	-19%	-$171K	0.01%	1242
2022 Q4	$927K	Sell	27,626 -15,029	-35%	-$459K	0.01%	970
2022 Q3	$1.29M	Buy	42,655 +25,123	+143%	+$921K	0.02%	1001
2022 Q2	$610K	Buy	+17,532	New	+$690K	0.01%	1284
2022 Q1	–	Sell	-22,995	Closed	-$1.15M	–	2295
2021 Q4	$1.15M	Buy	+22,995	New	+$1.5M	0.01%	995

Other funds holding DOCS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Michael Gelband's DOCS Position: Q1 2026 in Review

Michael Gelband sold out of Doximity (DOCS) in Q1 2026, closing a stake of 93,595 shares — an estimated $4.14M sold.

Michael Gelband first reported a position in DOCS in Q4 2021 and held it in 10 quarters. The position peaked at $4.14M in Q4 2025. 421 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

Michael Gelband reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
Michael Gelband sold 93,595 Doximity shares in Q1 2026, an estimated $4.14M.
Michael Gelband first reported a position in Doximity in Q4 2021 and held it in 10 quarters.
Michael Gelband's Doximity position peaked at $4.14M in Q4 2025.
421 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.